1. Primary pituitary lymphoma: an update of the literature

   • A. Tarabay
   • G. Cossu
   • M. Messerer

   Topic Review 31 August 2016 Pages: 383 - 395

   

2. Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation

   • Ted K. Yanagihara
   • Heva J. Saadatmand
   • Tony J. C. Wang

   Topic Review 08 September 2016 Pages: 397 - 411

3. Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients

   • Tal Shahar
   • Avital Granit
   • Iris Lavon

   Laboratory Investigation 29 August 2016 Pages: 413 - 422

   

4. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas

   • Kavneet Kaur
   • Aanchal Kakkar
   • Chitra Sarkar

   Laboratory Investigation 30 August 2016 Pages: 423 - 430

   

5. Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma

   • Emeline Tabouret
   • Emilie Denicolai
   • Olivier Chinot

   Laboratory Investigation 26 August 2016 Pages: 431 - 437

   

6. Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients

   • Charlotte Aaberg-Jessen
   • Bo Halle
   • Bjarne W. Kristensen

   Laboratory Investigation Open access 12 September 2016 Pages: 439 - 448

   

7. Safety, feasibility, and optimization of intra-arterial mitoxantrone delivery to gliomas

   • Jason A. Ellis
   • Johann Cooke
   • Shailendra Joshi

   Laboratory Investigation 30 August 2016 Pages: 449 - 454

   

8. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells

   • Malek Hossein Asadi
   • Khosrow Khalifeh
   • Seyed Javad Mowla

   Laboratory Investigation 01 September 2016 Pages: 455 - 463

   

9. Topiramate induces acute intracellular acidification in glioblastoma

   • Kamini Marathe
   • Nevin McVicar
   • Robert Bartha

   Laboratory Investigation 09 September 2016 Pages: 465 - 472

   

10. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas

    • M. Bujko
    • P. Kober
    • J. A. Siedlecki

    Laboratory Investigation Open access 10 September 2016 Pages: 473 - 484

    

11. Time-delayed contrast-enhanced MRI improves detection of brain metastases: a prospective validation of diagnostic yield

    • Or Cohen-Inbar
    • Zhiyuan Xu
    • Jason P. Sheehan

    Clinical Study 27 August 2016 Pages: 485 - 494

    

12. Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma

    • Allison F. O’Neill
    • Lei Qin
    • Jeffrey T. Yap

    Clinical Study 30 August 2016 Pages: 495 - 503

    

13. Occupational exposure to metals and risk of meningioma: a multinational case-control study

    • Siegal Sadetzki
    • Angela Chetrit
    • Elisabeth Cardis

    Clinical Study 23 September 2016 Pages: 505 - 515

14. Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study

    • Ian F. Pollack
    • Regina I. Jakacki
    • Hideho Okada

    Clinical Study 13 September 2016 Pages: 517 - 527

    

15. Molecular and histologic characteristics of pseudoprogression in diffuse gliomas

    • Andrew L. Lin
    • Michael White
    • Sonika Dahiya

    Clinical Study 04 October 2016 Pages: 529 - 533

    

16. Surgical management of posterior fossa metastases

    • Geraint J. Sunderland
    • Michael D. Jenkinson
    • Rasheed Zakaria

    Clinical Study Open access 12 September 2016 Pages: 535 - 542

    

17. Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma

    • Seunggu J. Han
    • Gerald Reis
    • Hideho Okada

    Clinical Study 13 September 2016 Pages: 543 - 552

    

18. Gamma Knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series

    • Brandon Birckhead
    • Terence T. Sio
    • Nadia N. Laack

    Clinical Study 05 November 2016 Pages: 553 - 560

    

19. Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis

    • Nasser Alshehri
    • David J. Cote
    • Timothy R. Smith

    Clinical Study 03 September 2016 Pages: 561 - 570

    

20. Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma

    • Edward Pan
    • Jeffrey G. Supko
    • Deric M. Park

    Clinical Study 08 November 2016 Pages: 571 - 579

    

21. A case-matched study of stereotactic radiosurgery for patients with brain metastases: comparing treatment results for those with versus without neurological symptoms

    • Takao Koiso
    • Masaaki Yamamoto
    • Bierta E. Barfod

    Clinical Study Open access 03 September 2016 Pages: 581 - 590

    

22. Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma

    • Oliver Schnell
    • Jun Thorsteinsdottir
    • Maximilian Niyazi

    Clinical Study 06 September 2016 Pages: 591 - 599

    

23. Long-term follow-up of a papillary tumor of the pineal region: addendum to a case report

    • Laura Lippa
    • Anna Maria Di Giacomo
    • Alfonso Cerase

    Letter to the Editor 27 August 2016 Pages: 601 - 603

    

24. Cerebellar dysfunction and spastic paraparesis associated to anti-Ri antibodies in a patient with a pancreatic neuroendocrine tumor

    • Abel Díaz Díaz
    • Miguel Hervás García
    • Ayoze González Hernández

    Letter to the Editor 03 September 2016 Pages: 605 - 606

    

25. Acknowledgement of reviewers 2015

    Acknowledgement 14 November 2016 Pages: 607 - 611